Adapthealth Corp
NASDAQ:AHCO
Intrinsic Value
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. [ Read More ]
The intrinsic value of one AHCO stock under the Base Case scenario is 31.78 USD. Compared to the current market price of 9.58 USD, Adapthealth Corp is Undervalued by 70%.
Valuation Backtest
Adapthealth Corp
Run backtest to discover the historical profit from buying and selling AHCO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Adapthealth Corp
Current Assets | 649m |
Cash & Short-Term Investments | 77.1m |
Receivables | 388.9m |
Other Current Assets | 183m |
Non-Current Assets | 3.9B |
PP&E | 637.5m |
Intangibles | 2.9B |
Other Non-Current Assets | 367m |
Current Liabilities | 537m |
Accounts Payable | 257.9m |
Accrued Liabilities | 163.4m |
Other Current Liabilities | 115.7m |
Non-Current Liabilities | 2.5B |
Long-Term Debt | 2.1B |
Other Non-Current Liabilities | 395.8m |
Earnings Waterfall
Adapthealth Corp
Revenue
|
3.2B
USD
|
Cost of Revenue
|
-2.6B
USD
|
Gross Profit
|
570.1m
USD
|
Operating Expenses
|
-311.9m
USD
|
Operating Income
|
258.2m
USD
|
Other Expenses
|
-937.1m
USD
|
Net Income
|
-678.9m
USD
|
Free Cash Flow Analysis
Adapthealth Corp
AHCO Profitability Score
Profitability Due Diligence
Adapthealth Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Adapthealth Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
AHCO Solvency Score
Solvency Due Diligence
Adapthealth Corp's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
Adapthealth Corp's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AHCO Price Targets Summary
Adapthealth Corp
According to Wall Street analysts, the average 1-year price target for AHCO is 12.09 USD with a low forecast of 7.07 USD and a high forecast of 16.8 USD.
Ownership
AHCO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AHCO Price
Adapthealth Corp
Average Annual Return | 45.72% |
Standard Deviation of Annual Returns | 121.33% |
Max Drawdown | -84% |
Market Capitalization | 1.3B USD |
Shares Outstanding | 132 990 000 |
Percentage of Shares Shorted | 7.91% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 10,700 full-time employees. The company went IPO on 2018-02-21. The firm is focused on providing sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps); home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The breadth of the Company’s product is particularly valuable to acute care hospitals, sleep laboratories and long-term care facilities that discharge patients with complex conditions and multiple product needs.
Contact
IPO
Employees
Officers
The intrinsic value of one AHCO stock under the Base Case scenario is 31.78 USD.
Compared to the current market price of 9.58 USD, Adapthealth Corp is Undervalued by 70%.